The Patent Finder

Oxidizing Agent for Modified Nucleotides

Biomodal Limited

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,563,248Oxidizing Agent for Modified Nucleotides
In force
 · High confidence
Biomodal LimitedIn forceHigh confidence
Application 18/633,308Oxidising Agent for Modified Nucleotides
Abandoned
Abandoned Nov 26, 2024
Biomodal LimitedAbandonedAbandoned Nov 26, 2024
Application 18/948,900Oxidising Agent for Modified Nucleotides
Abandoned
Abandoned Jul 21, 2025
Biomodal LimitedAbandonedAbandoned Jul 21, 2025
Application 19/263,873Oxidising Agent for Modified Nucleotides
Pending
Not granted
Biomodal LimitedPendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Biomodal Limited.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited